{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:29:21Z","timestamp":1783380561816,"version":"3.54.6"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s40272-018-0294-0","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T21:01:56Z","timestamp":1525381316000},"page":"331-335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Dose-Dependent Teratology in Humans: Clinical Implications for Prevention"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9234-0875","authenticated-orcid":false,"given":"Gideon","family":"Koren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matitiahu","family":"Berkovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asher","family":"Ornoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"294_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/jama.1994.03510260078033","volume":"271","author":"LS Cohen","year":"1994","unstructured":"Cohen LS, Friedman JM, Jefferson JW, et al. A reevaluation of risk of in utero exposure to lithium. JAMA. 1994;271:146\u201350.","journal-title":"JAMA"},{"key":"294_CR2","first-page":"95","volume":"45","author":"S Yacobi","year":"2008","unstructured":"Yacobi S, Ornoy A. Is lithium a real teratogen? What can we conclude from the prospective versus retrospective studies? A review. Isr J Psych Rel Dis. 2008;45:95\u2013106.","journal-title":"Isr J Psych Rel Dis."},{"key":"294_CR3","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1056\/NEJMoa1612222","volume":"376","author":"E Patorno","year":"2017","unstructured":"Patorno E, Huybrechts KF, Bateman BT, et al. Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med. 2017;376:2245\u201354.","journal-title":"N Engl J Med"},{"key":"294_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/tera.1420260304","volume":"26","author":"M Smithberg","year":"1982","unstructured":"Smithberg M, Dixit PK. Teratogenic effects of lithium in mice. Teratology. 1982;26:239\u201346.","journal-title":"Teratology."},{"key":"294_CR5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","volume":"10","author":"T Tomson","year":"2011","unstructured":"Tomson T, Battino D, Bonizzoni E, et al. EURAP study group. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol. 2011;10:609\u201317.","journal-title":"Lancet Neurol."},{"issue":"10","key":"294_CR6","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1212\/WNL.0000000000001772","volume":"85","author":"T Tomson","year":"2015","unstructured":"Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study. Neurology. 2015;85(10):866\u201372.","journal-title":"Neurology."},{"key":"294_CR7","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1468-1331.2006.01359.x","volume":"13","author":"FJ Vajda","year":"2006","unstructured":"Vajda FJ, Hitchcock A, Graham J, et al. Foetal malformations and seizure control: 52\u00a0months data of the Australian Pregnancy Registry. Eur J Neurol. 2006;13:645\u201354.","journal-title":"Eur J Neurol"},{"key":"294_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S1059-1311(02)00135-8","volume":"11","author":"G Mawer","year":"2002","unstructured":"Mawer G, Clayton-Smith J, Coyle H, et al. Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. Seizures. 2002;11:512\u20136.","journal-title":"Seizures"},{"key":"294_CR9","first-page":"CD010224","volume":"11","author":"J Weston","year":"2016","unstructured":"Weston J, Bromley R, Jackson CF, et al. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev. 2016;11:CD010224.","journal-title":"Cochrane Database Syst Rev."},{"key":"294_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2165\/00023210-200822040-00004","volume":"22","author":"O Diav-Citrin","year":"2008","unstructured":"Diav-Citrin O, Shechtman S, Bar-Oz B, et al. Pregnancy outcome after in utero exposure to valproate: evidence of dose relationship in teratogenic effect. CNS Drugs. 2008;22:325\u201334.","journal-title":"CNS Drugs"},{"key":"294_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/epi.13632","volume":"58","author":"SV Thomas","year":"2017","unstructured":"Thomas SV, Jose M, Divakaran S, et al. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: results from a pregnancy registry in South India. Epilepsia. 2017;58:274\u201381.","journal-title":"Epilepsia."},{"key":"294_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","volume":"84","author":"RL Bromley","year":"2013","unstructured":"Bromley RL, Mawer GE, Briggs M, et al. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013;84:637\u201343.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"294_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/ane.12280","volume":"130","author":"FJ Vajda","year":"2014","unstructured":"Vajda FJ, O\u2019Brien TJ, Lander CM, et al. The teratogenicity of the newer antiepileptic drugs\u2014an update. Acta Neurol Scand. 2014;130:234\u20138.","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"294_CR14","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1212\/WNL.0000000000004857","volume":"90","author":"S Hernandez-Diaz","year":"2018","unstructured":"Hernandez-Diaz S, Huybrechts KF, Desai RJ, et al. Topiramate use early in pregnancy and the risk of oral clefts: a pregnancy cohort study. Neurology. 2018;90(4):e342\u201351.","journal-title":"Neurology."},{"key":"294_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","volume":"77","author":"J Morrow","year":"2006","unstructured":"Morrow J, Russell A, Guthrie E, et al. Malformation risk of antiepileptic drugs in pregnancy: a prospective study from the UK epilepsy and pregnancy register. J Neurol Neurosurg Psychiatr. 2006;77:193\u20138.","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"294_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/(SICI)1520-6866(1996)16:2<97::AID-TCM4>3.0.CO;2-A","volume":"16","author":"E Menegola","year":"1996","unstructured":"Menegola E, Broccia ML, Nau H, et al. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term. Teratog Carcinog Mutagen. 1996;16:97\u2013108.","journal-title":"Teratog Carcinog Mutagen."},{"key":"294_CR17","first-page":"201","volume":"28","author":"SS Elshama","year":"2015","unstructured":"Elshama SS, Osman HE, El-Kenawy A-M. Teratogenic effect of carbamazepine use during pregnancy in the mice. Pak J Pharm Sci. 2015;28:201\u201312.","journal-title":"Pak J Pharm Sci."},{"key":"294_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/bdrb.21022","volume":"95","author":"SH Kim","year":"2012","unstructured":"Kim SH, Lee IC, Baek HS, et al. Dose-response effects of diphenylhydantoin on pregnant dams and embryo-fetal development in rats. Birth Defects Res B. 2012;95:337\u201345.","journal-title":"Birth Defects Res B"},{"key":"294_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.eplepsyres.2007.10.014","volume":"78","author":"JB Manent","year":"2008","unstructured":"Manent JB, Jorquera I, Franco V, et al. Antiepileptic drugs and brain maturation: fetal exposure to lamotrigine generates cortical malformations in rats. Epilepsy Res. 2008;78:131\u20139.","journal-title":"Epilepsy Res"},{"key":"294_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ajog.2008.06.032","volume":"200","author":"RL Brent","year":"2009","unstructured":"Brent RL. Saving lives and changing family histories: appropriate counseling of pregnant women and men and women of reproductive age, concerning the risk of diagnostic radiation exposures during and before pregnancy. Am J Obstet Gynecol. 2009;200:4\u201324.","journal-title":"Am J Obstet Gynecol"},{"key":"294_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1590\/S1020-49892006000800016","volume":"20","author":"RL Brent","year":"2006","unstructured":"Brent RL. Counseling patients exposed to ionizing radiation during pregnancy. Rev Panam Salud Publica. 2006;20:198\u2013204.","journal-title":"Rev Panam Salud Publica"},{"key":"294_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/HP.0000000000000235","volume":"108","author":"RL Brent","year":"2015","unstructured":"Brent RL. Protection of the gametes, embryo\/fetus from prenatal radiation exposure. Health Phys. 2015;108:242\u201374.","journal-title":"Health Phys"},{"key":"294_CR23","first-page":"456","volume":"203","author":"S Reinou","year":"2012","unstructured":"Reinou S, Groen S, Jin Y, et al. Fear of the unknown: ionizing radiation exposure during pregnancy. Am J Obst Gynecol. 2012;203:456\u201362.","journal-title":"Am J Obst Gynecol."},{"key":"294_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/FTD.0000000000000193","volume":"37","author":"YC Kaplan","year":"2015","unstructured":"Kaplan YC, Nulman I, Koren G. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Ther Drug Monit. 2015;37:557\u20138.","journal-title":"Ther Drug Monit"},{"key":"294_CR25","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1212\/WNL.0b013e3182a43e81","volume":"81","author":"FJ Vajda","year":"2013","unstructured":"Vajda FJ, O\u2019Brien TJ, Graham JE, et al. Dose dependence of fetal malformations associated with valproate. Neurology. 2013;81:999\u20131003.","journal-title":"Neurology"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-018-0294-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-018-0294-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-018-0294-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T19:24:59Z","timestamp":1556911499000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-018-0294-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["294"],"URL":"https:\/\/doi.org\/10.1007\/s40272-018-0294-0","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]},"assertion":[{"value":"4 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"GK, AO and MB declare no conflict of interests associated with this research. No funding was received for the conduct or publication of the research presented in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}